Norinchukin Bank The Acquires 18,931 Shares of Colgate-Palmolive (CL)
Norinchukin Bank The lifted its holdings in Colgate-Palmolive (NYSE:CL) by 4.6% in the third quarter, Holdings Channel reports. The fund owned 434,204 shares of the company’s stock after buying an additional 18,931 shares during the period. Colgate-Palmolive makes up 0.6% of Norinchukin Bank The’s investment portfolio, making the stock its 24th biggest position. Norinchukin Bank The’s holdings in Colgate-Palmolive were worth $31,632,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in CL. Vanguard Group Inc. increased its stake in shares of Colgate-Palmolive by 2.4% in the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after buying an additional 1,621,392 shares during the period. Renaissance Technologies LLC increased its stake in shares of Colgate-Palmolive by 42.4% in the second quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after buying an additional 2,903,800 shares during the period. Arrowstreet Capital Limited Partnership increased its stake in shares of Colgate-Palmolive by 25.3% in the second quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock worth $508,111,000 after buying an additional 1,385,946 shares during the period. First Eagle Investment Management LLC increased its stake in shares of Colgate-Palmolive by 35.8% in the third quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock worth $483,837,000 after buying an additional 1,750,417 shares during the period. Finally, TIAA CREF Investment Management LLC increased its stake in shares of Colgate-Palmolive by 3.7% in the second quarter. TIAA CREF Investment Management LLC now owns 4,725,042 shares of the company’s stock worth $350,267,000 after buying an additional 170,053 shares during the period. Hedge funds and other institutional investors own 72.83% of the company’s stock.
A number of research analysts have issued reports on CL shares. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Jefferies Group reissued a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 31st. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Finally, Macquarie started coverage on shares of Colgate-Palmolive in a research report on Thursday, September 14th. They set a “neutral” rating and a $76.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $76.33.
In related news, Director Stephen I. Sadove sold 20,780 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $70.52, for a total value of $1,465,405.60. Following the transaction, the director now owns 36,268 shares in the company, valued at approximately $2,557,619.36. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Jennifer Daniels sold 7,375 shares of the company’s stock in a transaction dated Wednesday, December 13th. The stock was sold at an average price of $73.18, for a total transaction of $539,702.50. Following the completion of the transaction, the insider now owns 38,691 shares in the company, valued at approximately $2,831,407.38. The disclosure for this sale can be found here. In the last quarter, insiders sold 181,048 shares of company stock worth $13,168,995. 1.02% of the stock is currently owned by company insiders.
Shares of Colgate-Palmolive (CL) opened at $75.42 on Friday. The firm has a market cap of $66,230.00, a PE ratio of 29.12, a PEG ratio of 3.21 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. Colgate-Palmolive has a 1 year low of $63.43 and a 1 year high of $77.27.
Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.73. The firm had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company’s revenue was up 2.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.73 EPS. research analysts anticipate that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.
WARNING: “Norinchukin Bank The Acquires 18,931 Shares of Colgate-Palmolive (CL)” was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of US and international copyright laws. The legal version of this news story can be accessed at https://www.watchlistnews.com/norinchukin-bank-the-acquires-18931-shares-of-colgate-palmolive-cl/1797771.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.